Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Non-cash Items (2019 - 2025)

Historic Non-cash Items for iBio (IBIO) over the last 10 years, with Q2 2025 value amounting to $228502.0.

  • iBio's Non-cash Items rose 343116.98% to $228502.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $228502.0, marking a year-over-year increase of 343116.98%. This contributed to the annual value of $228502.0 for FY2025, which is 343116.98% up from last year.
  • Latest data reveals that iBio reported Non-cash Items of $228502.0 as of Q2 2025, which was up 343116.98% from $6471.0 recorded in Q2 2024.
  • iBio's 5-year Non-cash Items high stood at $228502.0 for Q2 2025, and its period low was $4790.0 during Q2 2023.
  • Over the past 5 years, iBio's median Non-cash Items value was $77338.0 (recorded in 2021), while the average stood at $102901.0.
  • Its Non-cash Items has fluctuated over the past 5 years, first plummeted by 9808.66% in 2021, then soared by 343116.98% in 2025.
  • Quarter analysis of 5 years shows iBio's Non-cash Items stood at $77338.0 in 2021, then soared by 155.25% to $197404.0 in 2022, then crashed by 97.57% to $4790.0 in 2023, then surged by 35.09% to $6471.0 in 2024, then surged by 3431.17% to $228502.0 in 2025.
  • Its Non-cash Items stands at $228502.0 for Q2 2025, versus $6471.0 for Q2 2024 and $4790.0 for Q2 2023.